Project Details
| Short title | 421-01-02 |
|---|---|
| Acronym | 421-01-02 |
| Status | Active |
| Effective start/end date | 5/05/23 → 30/03/28 |
CTU: 421-01-02: A Phase 1b, Randomized, Double-Masked, Placebo-Controlled, Multiple Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of VB421 in Subjects With Thyroid Eye Disease (TED)
- Tumuluri, Krishna (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
- Contacos, Christine (Clinical Trial Unit Staff)
- Keshiya, Shikara (Clinical Trial Unit Staff)
Project: Research